Kan. Admin. Regs. § 28-21-268 - Price and fee control
(a) The maximum
reasonable price at which amygdalin (laetrile) may be sold to a pharmacist or
direct to a physician licensed in the state of Kansas shall be based on cost of
production for the product plus 25% (twenty-five percent). A cost of production
analysis report which has been approved by a certified public accountant shall
be submitted to the secretary of health and environment prior to establishment
of the wholesale cost of the product.
(b) No increase over and above the wholesale
or retail cost of amygdalin (laetrile) may be made by a physician who
administers or prescribes this product. The physician may charge a fee only for
his professional services in prescribing or administering amygdalin (laetrile).
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.